Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

Vascular toxicity associated with cancer therapies is a leading cause of cardiovascular adverse events in patients with ...

SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC ...

Dr. Hussein Tawbi, who works for MD Anderson in Houston, said there are two things he hopes people take away from the story ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...

More than two years after the Food and Drug Administration held a public workshop on measuring overall survival (OS) in ...

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

When they were created at the beginning of the COVID-19 pandemic, mRNA vaccines to treat the virus were considered a major ...